Transferring a research protocol between laboratories is rarely just a matter of sending a method document. The receiving lab needs to know exactly which vial, which catalogue item, which expiry date and which Certificate of Analysis (CoA) sit behind each material in the workflow. Without that chain, a protocol can appear reproducible on paper while the underlying traceability is ambiguous in practice. For research-use-only materials, the aim is a defensible record: SKU, label reference, expiry date, storage history, custody record and batch-specific CoA file, all linked together. This is an in-vitro documentation discipline, not a clinical or therapeutic process. Materials discussed here are not for human or veterinary use, consumption, administration or clinical application.
Building the traceability spine from SKU and expiry date to the CoA file
The traceability spine begins with the catalogue identifier. The SKU tells the receiving laboratory which catalogue item is being transferred, while the expiry date on the vial label gives the material a time boundary. Research Sciences describes a label reference format that combines the SKU code and expiry date, for example BPC10-03/27, linking to the corresponding CoA. That reference is the practical bridge between the physical vial and the document file. It should be quoted when contacting the shop about documentation, and it should be recorded in the receiving laboratory’s inventory before the vial enters storage.
A useful documentation pack does not rely on a catalogue page alone. It records the supplier trading name, SKU, full label reference, expiry date, quantity received, storage condition and the filename of the matching CoA. The original CoA should be kept unaltered, with any working copy clearly marked as a duplicate. In the protocol transfer record, the material identity should be written as the catalogue name plus the label reference, not just a shorthand such as “BPC”. That distinction matters when two vials of the same product family sit in the same freezer or when a restock arrives with similar packaging. The homepage lists “CoAs Janoshik Analytical Reports”, and the published FAQs describe a CoA for every product, with HPLC testing for purity and identity. Those statements should be reconfirmed on the live site, and the researcher should open the CoA that accompanies the specific batch rather than treating a catalogue-level claim as a batch result.
What the receiving lab should file first
Before the protocol transfer is accepted, the receiving laboratory should create a batch file containing the label reference, the unaltered CoA, the storage location and the transfer date. If the material is lyophilised, the file should note the storage condition described in the shop’s guidance: –20°C or below, sealed with desiccant, protected from moisture, heat and light, with repeated freeze–thaw cycles avoided. If the protocol uses reconstituted material for an in-vitro assay, the record should note the diluent volume and assay concentration only as laboratory workflow data. The shop’s calculator and materials are for laboratory research use only and must not be used for human or veterinary dosing. Materials remain research-use-only and are not for human or veterinary use.
Moving the protocol between labs: custody, storage and handover records
A protocol transfer between laboratories should include a material transfer manifest. At minimum, the manifest should list the SKU, label reference, expiry date, quantity, physical description, storage condition, CoA filename and the name of the person releasing and receiving the material. This is the practical form of chain of custody. If a vial is removed from a –20°C freezer, placed in a temperature-aware transfer container and handed to another site, the manifest and storage log should tell the same story. For lyophilised materials, the receiving lab should allow vials to reach room temperature before opening, work in a clean environment and remove only the amount required for the experiment. These are in-vitro handling notes, not instructions for administration or clinical use.
Where a protocol involves reconstitution for an in-vitro assay, the handover record should distinguish between the lyophilised stock and the reconstituted working material. The published FAQ guidance describes reconstituted peptides as less stable and recommends short-term laboratory storage at 2–8°C. The record should therefore include the reconstitution date, diluent volume, assay concentration and storage location, without converting that information into a dosing instruction. Materials are not medicines, medical devices, injectables, treatments or food supplements under UK law, and they are not supplied for therapeutic, clinical or diagnostic purposes. The receiving lab should check that the intended in-vitro application is lawful, suitable and covered by its own COSHH and laboratory safety procedures.
Documentation should travel with the material, not after it. Before a receiving laboratory relies on a catalogue description, it should check the live listing at Peptides uk and then open the CoA that accompanies the specific batch. Catalogue wording can help identify the item, but it does not replace the batch document. If the receiving lab orders replacement material, the published fulfilment terms should be reconfirmed at checkout; the shop describes next-working-day dispatch and Royal Mail Tracked 24 as an estimate, not a guaranteed arrival promise. The transfer file should record the tracking reference where applicable, but the core traceability link remains the SKU, expiry reference and CoA. Materials are not for human or veterinary use, and handling must remain within controlled laboratory and analytical research.
When records do not align: ITRs, restocks and discrepancy handling
Discrepancies are where traceability either holds or fails. Common issues include a damaged label, a CoA file that will not open, an expiry date that differs from the inventory entry, a SKU that matches the catalogue but not the transfer manifest, or a restock that looks similar but carries a different reference. The receiving laboratory should quarantine the vial, record the discrepancy and quote the full label reference when contacting the supplier. The published FAQ notes that restocked products may carry the same Internal Test Reference (ITR) as earlier stock. An ITR links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. Vial cap colours and other packaging may vary; cap colour is not an indicator of identity, analytical quality or manufacturing origin.
Older paperwork may show Imperial Sciences UK or Imperial Peptides UK, while the current site uses Research Sciences. The published FAQ describes Research Sciences as the parent company of Imperial Peptides UK, with Imperial Peptides UK continuing as a brand. For traceability, the receiving laboratory should record the trading name exactly as it appears on the document rather than assuming equivalence. The important link is still the label reference and the batch-specific CoA. If a CoA cannot be matched to the vial reference, the material should not enter the in-vitro workflow until the documentation query is resolved. This is especially important when a protocol is being transferred between organisations with different inventory systems or file-naming conventions.
If the receiving lab cannot match the label reference to a CoA within its own records, the transfer should pause at receipt, the vial should be quarantined, and the documentation query should be raised before the material enters the in-vitro workflow. Materials are research-use-only, not for human or veterinary use, and not for consumption, administration or clinical application. The practical rule is to keep the physical vial, the expiry reference and the CoA file moving together as one traceable unit.
Hailing from Zagreb and now based in Montréal, Helena is a former theater dramaturg turned tech-content strategist. She can pivot from dissecting Shakespeare’s metatheatre to reviewing smart-home devices without breaking iambic pentameter. Offstage, she’s choreographing K-pop dance covers or fermenting kimchi in mason jars.